Antibody response to 2-dose sars-cov-2 mrna vaccine series in solid organ transplant recipients

Brian J. Boyarsky; William A. Werbel; Robin K. Avery; Aaron A.R. Tobian; Allan B. Massie; Dorry L. Segev; Jacqueline M. Garonzik-Wang

doi:10.1001/jama.2021.7489

Antibody response to 2-dose sars-cov-2 mrna vaccine series in solid organ transplant recipients

Brian J. Boyarsky, William A. Werbel, Robin K. Avery, Aaron A.R. Tobian, Allan B. Massie, Dorry L. Segev, Jacqueline M. Garonzik-Wang

School of Medicine

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	2204-2206
Number of pages	3
Journal	JAMA - Journal of the American Medical Association
Volume	325
Issue number	21
DOIs	https://doi.org/10.1001/jama.2021.7489
State	Published - Jun 1 2021

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2021.7489

Cite this

@article{cfadfda1addc490bb1e95e6381ff3782,

title = "Antibody response to 2-dose sars-cov-2 mrna vaccine series in solid organ transplant recipients",

author = "Boyarsky, {Brian J.} and Werbel, {William A.} and Avery, {Robin K.} and Tobian, {Aaron A.R.} and Massie, {Allan B.} and Segev, {Dorry L.} and Garonzik-Wang, {Jacqueline M.}",

note = "Funding Information: Conflict of Interest Disclosures: Dr Werbel reported receiving grants from the American Society of Transplantation Research Network Clinical Science Fellowship Grant. Dr Avery reported receiving grants from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, and Takeda/Shire. Dr Segev reported serving as a consultant to and receiving honoraria for speaking from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, and Thermo Fisher Scientific. No other disclosures were reported. Funding Information: Funding/Support: This work was supported by the Ben-Dov family; grants F32DK124941 (Dr Boyarsky), K01DK101677 (Dr Massie), and K23DK115908 (Dr Garonzik-Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); grant K24AI144954 (Dr Segev) from the National Institute of Allergy and Infectious Diseases (NIAID); and by grant gSAN-201C0WW from the Transplantation and Immunology Research Network of the American Society of Transplantation (Dr Werbel).",

year = "2021",

month = jun,

day = "1",

doi = "10.1001/jama.2021.7489",

language = "English (US)",

volume = "325",

pages = "2204--2206",

journal = "JAMA - Journal of the American Medical Association",

issn = "0098-7484",

publisher = "American Medical Association",

number = "21",

}

TY - JOUR

T1 - Antibody response to 2-dose sars-cov-2 mrna vaccine series in solid organ transplant recipients

AU - Boyarsky, Brian J.

AU - Werbel, William A.

AU - Avery, Robin K.

AU - Tobian, Aaron A.R.

AU - Massie, Allan B.

AU - Segev, Dorry L.

AU - Garonzik-Wang, Jacqueline M.

N1 - Funding Information: Conflict of Interest Disclosures: Dr Werbel reported receiving grants from the American Society of Transplantation Research Network Clinical Science Fellowship Grant. Dr Avery reported receiving grants from Aicuris, Astellas, Chimerix, Merck, Oxford Immunotec, Qiagen, and Takeda/Shire. Dr Segev reported serving as a consultant to and receiving honoraria for speaking from Sanofi, Novartis, CSL Behring, Jazz Pharmaceuticals, Veloxis, Mallincrodt, and Thermo Fisher Scientific. No other disclosures were reported. Funding Information: Funding/Support: This work was supported by the Ben-Dov family; grants F32DK124941 (Dr Boyarsky), K01DK101677 (Dr Massie), and K23DK115908 (Dr Garonzik-Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); grant K24AI144954 (Dr Segev) from the National Institute of Allergy and Infectious Diseases (NIAID); and by grant gSAN-201C0WW from the Transplantation and Immunology Research Network of the American Society of Transplantation (Dr Werbel).

PY - 2021/6/1

Y1 - 2021/6/1

UR - http://www.scopus.com/inward/record.url?scp=85105719869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105719869&partnerID=8YFLogxK

U2 - 10.1001/jama.2021.7489

DO - 10.1001/jama.2021.7489

M3 - Letter

C2 - 33950155

AN - SCOPUS:85105719869

SN - 0098-7484

VL - 325

SP - 2204

EP - 2206

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

IS - 21

ER -

Antibody response to 2-dose sars-cov-2 mrna vaccine series in solid organ transplant recipients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this